Staar Surgical Company (SR3)
FSX
Closed
Aug 26, 2026
Day's Range
19.7852 wk Range
13.51Overview - SR3 - Staar Surgical Company
Key Statistics
Valuation
Enterprise Value
728.68M
P/E (Trailing)
‪282.57‬
P/E (Forward)
‪25.68‬
PEG Ratio
‪-2.59‬
Price / Sales (TTM)
‪2.92‬
Price / Book
‪3.19‬
EV / EBITDA
‪17.09‬
Profitability
Gross Margin
‪73.62%‬
Profit Margin
‪1.13%‬
Operating Margin
‪10.88%‬
Return on Assets
‪5.64%‬
Return on Equity
‪1.09%‬
Ownership
Shares Outstanding
49.78M
Float
26.12M
Held by Insiders
‪0.85%‬
Held by Institutions
‪111.61%‬
Price stats
Beta
‪1.23‬
50-Day Avg
‪22.72‬
200-Day Avg
‪20.67‬
Dividends
Payout Ratio
‪0.00%‬
Peers - SR3 - Staar Surgical Company
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on FSX.
Profile Summary - SR3 - Staar Surgical Company
About
Staar Surgical Company designs, develops, manufactures, and sells implantable lenses for eye surgery, operating primarily in the ophthalmic medical devices sector. The company offers two main product categories: Implantable Collamer lenses (ICL) used in refractive surgery to correct vision problems without removing…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
